MLPAX
Price
$8.41
Change
+$0.15 (+1.82%)
Updated
Dec 20 closing price
SPMHX
Price
$8.55
Change
+$0.14 (+1.66%)
Updated
Dec 20 closing price
Ad is loading...

MLPAX vs SPMHX

Header iconMLPAX vs SPMHX Comparison
Open Charts MLPAX vs SPMHXBanner chart's image
Invesco SteelPath MLP Alpha A
Price$8.41
Change+$0.15 (+1.82%)
VolumeN/A
CapitalizationN/A
Invesco SteelPath MLP Alpha R5
Price$8.55
Change+$0.14 (+1.66%)
VolumeN/A
CapitalizationN/A
MLPAX vs SPMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MLPAX vs. SPMHX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPAX is a Buy and SPMHX is a Buy.

FUNDAMENTALS
Fundamentals
MLPAX (1.18B) and SPMHX (1.18B) have equal amount of cash in the bank . MLPAX (5.19) and SPMHX (5.12) have matching dividends . MLPAX was incepted earlier than SPMHX: MLPAX (15 years) vs SPMHX (6 years). MLPAX (32.00) and SPMHX (32.00) have comparable annual turnover. MLPAX has a lower initial minimum investment than SPMHX: MLPAX (1000) vs SPMHX (1000000). SPMHX (40.05) and MLPAX (39.83) have marching annual gain over last year. SPMHX (121.26) and MLPAX (118.69) have equivalent 5 years return.
MLPAXSPMHXMLPAX / SPMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years6 years-
Gain YTD38.95439.18999%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.18B1.18B100%
Annual Yield % from dividends5.195.12101%
Returns for 1 year39.8340.0599%
Returns for 3 years124.59125.8399%
Returns for 5 years118.69121.2698%
Returns for 10 years35.14N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSDT0.910.43
+89.58%
Helius Medical Technologies
MLYS12.340.51
+4.31%
Mineralys Therapeutics
SOL1.820.03
+1.68%
Emeren Group Ltd
MWA22.940.07
+0.31%
Mueller Water Products
SRPT118.97-0.50
-0.42%
Sarepta Therapeutics